Summary
Health and Human Services Secretary Robert F. Kennedy Jr. has decided to cancel 22 projects worth $500 million that were aimed at developing mRNA vaccines for respiratory viruses like COVID-19 and the flu. This move, part of Kennedy's broader actions against mRNA vaccines, involves stopping contracts with major pharmaceutical companies, including Pfizer and Moderna.
Key Facts
- Robert F. Kennedy Jr. announced the cancellation of $500 million worth of mRNA vaccine development projects.
- 22 projects focused on vaccines for viruses such as COVID-19 and the flu will be halted.
- The decision affects projects by leading pharmaceutical companies, including Pfizer and Moderna.
- Kennedy aims to prioritize other vaccine technologies, believing them to be safer.
- Experts argue that mRNA technology is safe and crucial for responding to pandemics.
- mRNA vaccines have historically helped slow down the spread of COVID-19.
- The current mRNA projects do not include existing approved COVID-19 and RSV vaccines.
- The HHS statement assures that other uses of mRNA technology remain unaffected.
